Non-steroidal Anti-Inflammatory Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Drug Class, Route Of Administration, Indication, Distribution Channel, and Geography

Description

List of Tables

The nonsteroidal anti-inflammatory drugs (NSAID) market size is projected to rise from US$ 24.82 billion in 2024 to US$ 38.38 billion by 2031; the market is expected to register a CAGR of 6.5% during 2025-2031.

Major factors propelling the market growth include the increasing prevalence of chronic pain disorders and inflammatory conditions such as arthritis and headaches, and the surging adoption of non-opioid NSAIDs. Further, the personalized and precision medicine approaches in NSAIDS use will likely boost the nonsteroidal anti-inflammatory drugs (NSAID) market growth during the forecast period. However, the increasing regulatory and development barriers is among the market deterrents.

According to the World Health Organization, approximately 528 million people globally were affected by osteoarthritis in 2019-a figure that has more than doubled since 1990. Notably, 73% of osteoarthritis sufferers are over the age of 55, and females account for 60% of this population. In 2020, 619 million individuals worldwide experienced lower back pain, with projections indicating this number could rise to 843 million by 2050.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for managing pain associated with conditions such as osteoarthritis, muscle injuries, headaches, and neuropathies. As the global population ages and chronic inflammatory diseases become more prevalent, the demand for effective pain management solutions continues to grow. NSAIDs offer a proven and efficient method for treating pain and inflammation. In response, pharmaceutical companies are innovating with new NSAID formulations to address diverse patient needs. For example, in January 2023, VaroJ Pharma launched its diclofenac epolamine topical system 1.3%, the authorized generic of IBSA Pharma's Flector (diclofenac epolamine), designed specifically for treating acute pain from strains, sprains, and contusions.

Moreover, recent advances in cancer therapies have led to a rise in cancer survivorship, accompanied by an increase in chronic pain conditions such as chemotherapy-induced peripheral neuropathy (CIPN). Based on a meta-analysis published in Regional Anesthesia and Pain Medicine in January 2025, CIPN affects around 41.2% of chronic pain patients, with notably higher rates among those undergoing platinum or taxane-based chemotherapy-60.26% prevalence in lung cancer patients. Neuropathic pain resulting from nerve damage, combined with musculoskeletal and inflammatory conditions, is substantially expanding the market for NSAIDs and related analgesics.

Therefore, the demand of NSAIDs for the treatment of prevalent chronic diseases is increasing the nonsteroidal anti-inflammatory drugs (NSAID) market growth.

The comparative company analysis evaluates and categorizes the nonsteroidal anti-inflammatory drugs (NSAID) market forecast based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global nonsteroidal anti-inflammatory drugs (NSAID) market. The key market players are B Pfizer, Bayer AG, Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd, Boehringer Ingelheim International GmbH, Haleon plc, Sun Pharmaceutical Industries Ltd, Novartis AG, Hikma Pharmaceuticals, Viatris Inc.

By drug class, the market is segmented into nonselective NSAIDS and cox-2 selective NSAIDs. The nonselective NSAIDS segment held the largest nonsteroidal anti-inflammatory drugs (NSAID) market share in 2024 and is expected to register the highest CAGR during 2025-2031.

By route of administration, the nonsteroidal anti-inflammatory drugs (NSAID) market is classified into oral, injectable and topical. The oral segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is expected to register a higher CAGR during 2025-2031.

In terms of indication, the nonsteroidal anti-inflammatory drugs (NSAID) market is segmented into arthritis, migraine, ophthalmic diseases, and others. The arthritis segment dominated the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is anticipated to register the highest CAGR during 2025-2031.

The market, based on distribution channel, is segmented into hospital pharmacies, retail pharmacies and online channels. The retail pharmacies segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024. Hospital pharmacies are playing an increasingly prominent role in managing chronic diseases and ensuring access to affordable medications. Hospital pharmacies play a crucial role in providing prescription NSAIDs to inpatients and discharged surgical patients. Professional oversight in these settings ensures safe and effective pain relief, particularly with newer and more potent injectable formulations. Recent innovations driving this growth include fixed-dose migraine treatments, such as meloxicam combined with rizatriptan, as well as the introduction of biosimilar NSAIDs aimed at reducing costs and increasing accessibility. Moreover, the shift toward personalized medicine, which involves targeted NSAIDs designed to minimize side effects, is promoting greater adoption in hospital environments, where close physician monitoring is essential. These factors are contributing to increased demand for NSAIDs and expanding their distribution through hospital pharmacies globally.

Various organic and inorganic strategies are adopted by companies operating in the nonsteroidal anti-inflammatory drugs (NSAID) market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios.

Product Code: TIPRE00004421

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Landscape

4.1 PEST Analysis

5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics

5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Chronic Pain Disorders and Inflammatory Diseases
- 5.2.2 Shifting Preference for NSAIDs as Non-Opioid Pain Management
5.3 Market Restraints
- 5.3.1 Regulatory and Development Barriers
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Personalized and Precision Medicine Approaches in NSAIDs Use
5.6 Impact of Drivers and Restraints:

6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Global Market Analysis

6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021-2031
6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast Analysis

7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Drug Class

7.1 Non-Selective NSAIDs
- 7.1.1 Overview
- 7.1.2 Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
7.2 COX-2 Selective NSAIDs
- 7.2.1 Overview
- 7.2.2 COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Route of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Injectable
- 8.2.1 Overview
- 8.2.2 Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Topical
- 8.3.1 Overview
- 8.3.2 Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Indication

9.1 Arthritis
- 9.1.1 Overview
- 9.1.2 Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Migraine
- 9.2.1 Overview
- 9.2.2 Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Ophthalmic Diseases
- 9.3.1 Overview
- 9.3.2 Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Distribution Channel

10.1 Hospital Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
- 10.2.1 Overview
- 10.2.2 Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Online Channels
- 10.3.1 Overview
- 10.3.2 Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Geographical Analysis

11.1 Overview
11.2 North America
- 11.2.1 North America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
- 11.2.2 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
- 11.2.3 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
  - 11.2.3.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
- 11.2.4 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
  - 11.2.4.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
- 11.2.5 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
  - 11.2.5.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
- 11.2.6 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.2.6.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.2.7 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.2.1 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.2.7.2.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.2.7.2.3 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.2.7.2.4 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.2.7.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.3.1 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.2.7.3.2 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.2.7.3.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.2.7.3.4 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.2.7.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.4.1 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.2.7.4.2 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.2.7.4.3 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.2.7.4.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
11.3 Europe
- 11.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
- 11.3.2 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
- 11.3.3 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
  - 11.3.3.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
- 11.3.4 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
  - 11.3.4.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
- 11.3.5 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
  - 11.3.5.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
- 11.3.6 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.6.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.3.7 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.2.1 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.2.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.2.3 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.2.4 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.7.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.3.1 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.3.2 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.3.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.3.4 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.7.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.4.1 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.4.2 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.4.3 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.4.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.7.5 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.5.1 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.5.2 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.5.3 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.5.4 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.7.6 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.6.1 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.6.2 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.6.3 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.6.4 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.3.7.7 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.7.1 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.3.7.7.2 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.3.7.7.3 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.3.7.7.4 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
11.4 Asia Pacific
- 11.4.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
- 11.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
- 11.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
  - 11.4.3.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
- 11.4.4 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
  - 11.4.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
- 11.4.5 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
  - 11.4.5.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
- 11.4.6 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.6.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.4.7 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.2.1 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.2.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.2.3 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.2.4 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.7.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.3.1 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.3.2 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.3.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.3.4 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.7.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.4.1 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.4.2 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.4.3 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.4.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.7.5 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.5.1 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.5.2 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.5.3 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.5.4 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.7.6 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.6.1 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.6.2 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.6.3 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.6.4 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.4.7.7 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.7.1 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.4.7.7.2 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.4.7.7.3 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.4.7.7.4 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
- 11.5.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
- 11.5.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
- 11.5.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
  - 11.5.3.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
- 11.5.4 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
  - 11.5.4.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
- 11.5.5 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
  - 11.5.5.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
- 11.5.6 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.5.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.5.7 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.2.1 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.5.7.2.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.5.7.2.3 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.5.7.2.4 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.5.7.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.3.1 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.5.7.3.2 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.5.7.3.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.5.7.3.4 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.5.7.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.4.1 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.5.7.4.2 South Africa: Non-steroidal Anti-inflmatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.5.7.4.3 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.5.7.4.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.5.7.5 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.5.1 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.5.7.5.2 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.5.7.5.3 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.5.7.5.4 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
11.6 South and Central America
- 11.6.1 South and Central America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
- 11.6.2 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
- 11.6.3 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
  - 11.6.3.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
- 11.6.4 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
  - 11.6.4.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
- 11.6.5 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
  - 11.6.5.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
- 11.6.6 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.6.6.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.6.7 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.2.1 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.6.7.2.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.6.7.2.3 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.6.7.2.4 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.6.7.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.3.1 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.6.7.3.2 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.6.7.3.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.6.7.3.4 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  - 11.6.7.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.4.1 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
    - 11.6.7.4.2 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
    - 11.6.7.4.3 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
    - 11.6.7.4.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024

13. Industry Landscape

13.1 Expansion
13.2 New Product Development
13.3 Other Business Strategies

14. Company Profiles

14.1 Pfizer Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bayer AG
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Dr. Reddy's Laboratories Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Glenmark Pharmaceuticals Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sun Pharmaceutical Industries Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Novartis AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hikma Pharmaceuticals Plc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Boehringer Ingelheim International GmbH
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Haleon Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 Glossary of Terms
15.2 About The Insight Partners